Jupiter Mines Limited Releases USD162 Million Profit From Tshipi Performance In FY19

Jupiter Mines

Jupiter Mines Limited (ASX: JMS) owns 49.9% beneficial interest in manganese mine Tshipi Borwa, located in the manganese rich Kalahari Manganese Field, North Cape Province, South Africa. Tshipi is flagged as one of the largest and lowest cost manganese exporters globally. The company is operating Tshipi mine at a cost of A$100m on a debt free basis with strong cash generation capabilities.

Australia based Jupiter mines possess the rights to market 49.9% of Tshipi production, earning a 3% marketing fee commission calculated off free-on-board revenue. In the fiscal year 2018 the company sold 1.7Mt of manganese which generated marketing fee income of A$10 million. Whereas in H1 2019 it sold 0.9Mt, earning a marketing fee income of A$6.5 million. Tshipi free-on-board cost of production was ~US$1.96 per dmtu and ~US$2.28 per dmtu in FY18 and FY19 year-to-date, respectively. Whereas, current spot manganese price at 37% FOB PE is US$6.22 / dmtu. 

Recently, Tshipi has negotiated a 5-year rail contract with Transnet under which the allocated tonnage is 2.1 mtpa effective February 2018 with expiry date of 2023. Jupiter’s total production from Tshipi was 2.33 million tonnes in FY2017 out of which 2.29 million tonnes was transported via Transnet. In FY2018 Tshipi’s total production increased to 3.64 million tonnes, including 2.31 million tonnes transported via Transnet.

In FY19 half year starting from 1 March 2018 to 31 August 2018, Tshipi’s net profit after tax was USD162 million whereas in FY18 NPAT was USD145 million. Earnings, before interest tax, depreciation and amortization was USD205 million in 1H FY19 period to 31 August 2018.

With primary focus on cash returns to shareholders, Jupiter distributed $98 million H1 2019 dividend to its shareholders on 10 October 2018. This dividend that equates to $0.05 per share represents the dividend yield of 16.1% H1 2019.

The share price of Jupiter Mines has fallen by 1.538% or $0.005 to $0.320 on 16 October 2018. Since its listing in April 2018, the stock has seen a performance change of -18.75% over the past six months.

Sponsored ad by Kalkine

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here